Bevacizumab and aflibercept can cause a decrease in VEGFA effects and an increase in CD206 + and Tie-2 + macrophages in murine and human gliomas through increasing Ang2 levels [57]. The gene discussed is VEGFA; the disease is central nervous system cancer.